MedX Health Corp
MDXHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.90 | 0.00 | -0.00 | -0.00 |
| FCF Yield | -3.34% | -439.02% | -155.67% | -194.71% |
| EV / EBITDA | -33.51 | -8.13 | -6.63 | -22.50 |
| Quality | ||||
| ROIC | 56.19% | 62.16% | 62.51% | 21.86% |
| Gross Margin | 27.53% | 19.91% | 42.91% | 38.91% |
| Cash Conversion Ratio | 0.54 | 1.06 | 0.31 | 0.54 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.64% | -6.33% | -0.08% | -1.38% |
| Free Cash Flow Growth | 50.50% | -184.72% | 18.34% | 14.53% |
| Safety | ||||
| Net Debt / EBITDA | -9.74 | -7.79 | -6.37 | -21.53 |
| Interest Coverage | -2.17 | -2.43 | -3.03 | -0.43 |
| Efficiency | ||||
| Inventory Turnover | 0.25 | 0.17 | 0.16 | 0.31 |
| Cash Conversion Cycle | -46.56 | -277.84 | -421.81 | 171.80 |